 | • レポートコード：MRC2012A6487 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、核内受容体RORガンマの世界市場を広く調査・分析し、今後の市場展望をまとめております。核内受容体RORガンマの種類別市場規模（BBI-6000、GRC-39815アクション、研究・開発プロセス、GSK-2981278、IMU-366、INV-17、その他）、用途別市場規模（慢性閉塞性肺疾患、喘息、軸性脊椎関節炎、乳がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Genfit SA、Brickell Biotech Inc、Beijing Hanmi Pharmaceutical、GlaxoSmithKline Plc、Eurofins Advinus、Aurigene Discovery Technologies、Phenex Pharmaceuticals AG、AbbVie Inc、Biogen Inc、Pfizer Inc、Glenmark Pharmaceuticals、Reata Pharmaceuticals Inc、Lead Pharma Holding BV、Eli Lilly、Bristol-Myers Squibb Company、Celgene Corp、 ・地域別グローバル市場分析 2015年-2020年 ・核内受容体RORガンマの北米市場（アメリカ、カナダ、メキシコ） ・核内受容体RORガンマのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・核内受容体RORガンマのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・核内受容体RORガンマの南米市場（ブラジル、アルゼンチン） ・核内受容体RORガンマの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：BBI-6000、GRC-39815アクション、研究・開発プロセス、GSK-2981278、IMU-366、INV-17、その他 ・用途別分析：慢性閉塞性肺疾患、喘息、軸性脊椎関節炎、乳がん、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Nuclear Receptor ROR Gamma market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nuclear Receptor ROR Gamma market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nuclear Receptor ROR Gamma market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nuclear Receptor ROR Gamma market has been segmented into
BBI-6000
GRC-39815Action
R&D Progress
GSK-2981278
IMU-366
INV-17
Others
By Application, Nuclear Receptor ROR Gamma has been segmented into:
Chronic Obstructive Pulmonary Disease
Asthma
Axial Spondyloarthritis
Breast Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Receptor ROR Gamma market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Receptor ROR Gamma markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Receptor ROR Gamma market.
The report offers in-depth assessment of the growth and other aspects of the Nuclear Receptor ROR Gamma market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nuclear Receptor ROR Gamma Market Share Analysis
Nuclear Receptor ROR Gamma competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nuclear Receptor ROR Gamma sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Receptor ROR Gamma sales, revenue and market share for each player covered in this report.
The major players covered in Nuclear Receptor ROR Gamma are:
Genfit SA
Brickell Biotech Inc
Beijing Hanmi Pharmaceutical
GlaxoSmithKline Plc
Eurofins Advinus
Aurigene Discovery Technologies
Phenex Pharmaceuticals AG
AbbVie Inc
Biogen Inc
Pfizer Inc
Glenmark Pharmaceuticals
Reata Pharmaceuticals Inc
Lead Pharma Holding BV
Eli Lilly
Bristol-Myers Squibb Company
Celgene Corp
Among other players domestic and global, Nuclear Receptor ROR Gamma market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nuclear Receptor ROR Gamma product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nuclear Receptor ROR Gamma, with price, sales, revenue and global market share of Nuclear Receptor ROR Gamma in 2018 and 2019.
Chapter 3, the Nuclear Receptor ROR Gamma competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nuclear Receptor ROR Gamma breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nuclear Receptor ROR Gamma market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nuclear Receptor ROR Gamma sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nuclear Receptor ROR Gamma Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nuclear Receptor ROR Gamma Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 BBI-6000
1.2.3 GRC-39815Action
1.2.4 R&D Progress
1.2.5 GSK-2981278
1.2.6 IMU-366
1.2.7 INV-17
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nuclear Receptor ROR Gamma Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Chronic Obstructive Pulmonary Disease
1.3.3 Asthma
1.3.4 Axial Spondyloarthritis
1.3.5 Breast Cancer
1.3.6 Others
1.4 Overview of Global Nuclear Receptor ROR Gamma Market
1.4.1 Global Nuclear Receptor ROR Gamma Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genfit SA
2.1.1 Genfit SA Details
2.1.2 Genfit SA Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Genfit SA SWOT Analysis
2.1.4 Genfit SA Product and Services
2.1.5 Genfit SA Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Brickell Biotech Inc
2.2.1 Brickell Biotech Inc Details
2.2.2 Brickell Biotech Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Brickell Biotech Inc SWOT Analysis
2.2.4 Brickell Biotech Inc Product and Services
2.2.5 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Beijing Hanmi Pharmaceutical
2.3.1 Beijing Hanmi Pharmaceutical Details
2.3.2 Beijing Hanmi Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Beijing Hanmi Pharmaceutical SWOT Analysis
2.3.4 Beijing Hanmi Pharmaceutical Product and Services
2.3.5 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline Plc
2.4.1 GlaxoSmithKline Plc Details
2.4.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline Plc SWOT Analysis
2.4.4 GlaxoSmithKline Plc Product and Services
2.4.5 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eurofins Advinus
2.5.1 Eurofins Advinus Details
2.5.2 Eurofins Advinus Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eurofins Advinus SWOT Analysis
2.5.4 Eurofins Advinus Product and Services
2.5.5 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Aurigene Discovery Technologies
2.6.1 Aurigene Discovery Technologies Details
2.6.2 Aurigene Discovery Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Aurigene Discovery Technologies SWOT Analysis
2.6.4 Aurigene Discovery Technologies Product and Services
2.6.5 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Phenex Pharmaceuticals AG
2.7.1 Phenex Pharmaceuticals AG Details
2.7.2 Phenex Pharmaceuticals AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Phenex Pharmaceuticals AG SWOT Analysis
2.7.4 Phenex Pharmaceuticals AG Product and Services
2.7.5 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AbbVie Inc
2.8.1 AbbVie Inc Details
2.8.2 AbbVie Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AbbVie Inc SWOT Analysis
2.8.4 AbbVie Inc Product and Services
2.8.5 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biogen Inc
2.9.1 Biogen Inc Details
2.9.2 Biogen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biogen Inc SWOT Analysis
2.9.4 Biogen Inc Product and Services
2.9.5 Biogen Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer Inc
2.10.1 Pfizer Inc Details
2.10.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer Inc SWOT Analysis
2.10.4 Pfizer Inc Product and Services
2.10.5 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Glenmark Pharmaceuticals
2.11.1 Glenmark Pharmaceuticals Details
2.11.2 Glenmark Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Glenmark Pharmaceuticals SWOT Analysis
2.11.4 Glenmark Pharmaceuticals Product and Services
2.11.5 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Reata Pharmaceuticals Inc
2.12.1 Reata Pharmaceuticals Inc Details
2.12.2 Reata Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Reata Pharmaceuticals Inc SWOT Analysis
2.12.4 Reata Pharmaceuticals Inc Product and Services
2.12.5 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Lead Pharma Holding BV
2.13.1 Lead Pharma Holding BV Details
2.13.2 Lead Pharma Holding BV Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Lead Pharma Holding BV SWOT Analysis
2.13.4 Lead Pharma Holding BV Product and Services
2.13.5 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Eli Lilly
2.14.1 Eli Lilly Details
2.14.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Eli Lilly SWOT Analysis
2.14.4 Eli Lilly Product and Services
2.14.5 Eli Lilly Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Bristol-Myers Squibb Company
2.15.1 Bristol-Myers Squibb Company Details
2.15.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Bristol-Myers Squibb Company SWOT Analysis
2.15.4 Bristol-Myers Squibb Company Product and Services
2.15.5 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Celgene Corp
2.16.1 Celgene Corp Details
2.16.2 Celgene Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Celgene Corp SWOT Analysis
2.16.4 Celgene Corp Product and Services
2.16.5 Celgene Corp Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nuclear Receptor ROR Gamma Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nuclear Receptor ROR Gamma Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nuclear Receptor ROR Gamma Manufacturer Market Share in 2019
3.3.2 Top 6 Nuclear Receptor ROR Gamma Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nuclear Receptor ROR Gamma Sales, Revenue and Market Share by Regions
4.1.1 Global Nuclear Receptor ROR Gamma Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nuclear Receptor ROR Gamma Revenue and Market Share by Regions (2015-2020)
4.2 North America Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
4.3 Europe Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
4.5 South America Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nuclear Receptor ROR Gamma Sales, Revenue and Market Share by Country
5.1.1 North America Nuclear Receptor ROR Gamma Sales and Market Share by Country (2015-2020)
5.1.2 North America Nuclear Receptor ROR Gamma Revenue and Market Share by Country (2015-2020)
5.2 United States Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
5.3 Canada Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
5.4 Mexico Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nuclear Receptor ROR Gamma Sales, Revenue and Market Share by Country
6.1.1 Europe Nuclear Receptor ROR Gamma Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nuclear Receptor ROR Gamma Revenue and Market Share by Country (2015-2020)
6.2 Germany Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
6.3 UK Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
6.4 France Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
6.5 Russia Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
6.6 Italy Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nuclear Receptor ROR Gamma Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nuclear Receptor ROR Gamma Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nuclear Receptor ROR Gamma Revenue and Market Share by Regions (2015-2020)
7.2 China Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
7.3 Japan Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
7.4 Korea Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
7.5 India Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
7.7 Australia Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nuclear Receptor ROR Gamma Sales, Revenue and Market Share by Country
8.1.1 South America Nuclear Receptor ROR Gamma Sales and Market Share by Country (2015-2020)
8.1.2 South America Nuclear Receptor ROR Gamma Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
8.3 Argentina Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nuclear Receptor ROR Gamma Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nuclear Receptor ROR Gamma Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nuclear Receptor ROR Gamma Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
9.3 Turkey Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
9.4 Egypt Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
9.5 South Africa Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nuclear Receptor ROR Gamma Sales and Market Share by Type (2015-2020)
10.2 Global Nuclear Receptor ROR Gamma Revenue and Market Share by Type (2015-2020)
10.3 Global Nuclear Receptor ROR Gamma Price by Type (2015-2020)
11 Global Nuclear Receptor ROR Gamma Market Segment by Application
11.1 Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2015-2020)
11.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2015-2020)
11.3 Global Nuclear Receptor ROR Gamma Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nuclear Receptor ROR Gamma Sales, Revenue and Growth Rate (2021-2025)
12.2 Nuclear Receptor ROR Gamma Market Forecast by Regions (2021-2025)
12.2.1 North America Nuclear Receptor ROR Gamma Market Forecast (2021-2025)
12.2.2 Europe Nuclear Receptor ROR Gamma Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nuclear Receptor ROR Gamma Market Forecast (2021-2025)
12.2.4 South America Nuclear Receptor ROR Gamma Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nuclear Receptor ROR Gamma Market Forecast (2021-2025)
12.3 Nuclear Receptor ROR Gamma Market Forecast by Type (2021-2025)
12.3.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Type (2021-2025)
12.3.2 Global Nuclear Receptor ROR Gamma Market Share Forecast by Type (2021-2025)
12.4 Nuclear Receptor ROR Gamma Market Forecast by Application (2021-2025)
12.4.1 Global Nuclear Receptor ROR Gamma Sales Forecast by Application (2021-2025)
12.4.2 Global Nuclear Receptor ROR Gamma Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nuclear Receptor ROR Gamma Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nuclear Receptor ROR Gamma by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nuclear Receptor ROR Gamma Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Genfit SA Basic Information, Manufacturing Base and Competitors
Table 8. Genfit SA Nuclear Receptor ROR Gamma Major Business
Table 9. Genfit SA Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 10. Genfit SA SWOT Analysis
Table 11. Genfit SA Nuclear Receptor ROR Gamma Product and Services
Table 12. Genfit SA Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Brickell Biotech Inc Basic Information, Manufacturing Base and Competitors
Table 14. Brickell Biotech Inc Nuclear Receptor ROR Gamma Major Business
Table 15. Brickell Biotech Inc Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 16. Brickell Biotech Inc SWOT Analysis
Table 17. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product and Services
Table 18. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Beijing Hanmi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Major Business
Table 21. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 22. Beijing Hanmi Pharmaceutical SWOT Analysis
Table 23. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product and Services
Table 24. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 26. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Major Business
Table 27. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 28. GlaxoSmithKline Plc SWOT Analysis
Table 29. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product and Services
Table 30. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eurofins Advinus Basic Information, Manufacturing Base and Competitors
Table 32. Eurofins Advinus Nuclear Receptor ROR Gamma Major Business
Table 33. Eurofins Advinus Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 34. Eurofins Advinus SWOT Analysis
Table 35. Eurofins Advinus Nuclear Receptor ROR Gamma Product and Services
Table 36. Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Aurigene Discovery Technologies Basic Information, Manufacturing Base and Competitors
Table 38. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Major Business
Table 39. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 40. Aurigene Discovery Technologies SWOT Analysis
Table 41. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product and Services
Table 42. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Phenex Pharmaceuticals AG Basic Information, Manufacturing Base and Competitors
Table 44. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Major Business
Table 45. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 46. Phenex Pharmaceuticals AG SWOT Analysis
Table 47. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product and Services
Table 48. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 50. AbbVie Inc Nuclear Receptor ROR Gamma Major Business
Table 51. AbbVie Inc Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 52. AbbVie Inc SWOT Analysis
Table 53. AbbVie Inc Nuclear Receptor ROR Gamma Product and Services
Table 54. AbbVie Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Biogen Inc Basic Information, Manufacturing Base and Competitors
Table 56. Biogen Inc Nuclear Receptor ROR Gamma Major Business
Table 57. Biogen Inc Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 58. Biogen Inc SWOT Analysis
Table 59. Biogen Inc Nuclear Receptor ROR Gamma Product and Services
Table 60. Biogen Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Inc Nuclear Receptor ROR Gamma Major Business
Table 63. Pfizer Inc Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 64. Pfizer Inc SWOT Analysis
Table 65. Pfizer Inc Nuclear Receptor ROR Gamma Product and Services
Table 66. Pfizer Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Major Business
Table 69. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 70. Glenmark Pharmaceuticals SWOT Analysis
Table 71. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product and Services
Table 72. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Reata Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 74. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Major Business
Table 75. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 76. Reata Pharmaceuticals Inc SWOT Analysis
Table 77. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product and Services
Table 78. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Lead Pharma Holding BV Basic Information, Manufacturing Base and Competitors
Table 80. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Major Business
Table 81. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 82. Lead Pharma Holding BV SWOT Analysis
Table 83. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product and Services
Table 84. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 86. Eli Lilly Nuclear Receptor ROR Gamma Major Business
Table 87. Eli Lilly Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 88. Eli Lilly SWOT Analysis
Table 89. Eli Lilly Nuclear Receptor ROR Gamma Product and Services
Table 90. Eli Lilly Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 92. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Major Business
Table 93. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 94. Bristol-Myers Squibb Company SWOT Analysis
Table 95. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product and Services
Table 96. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Celgene Corp Basic Information, Manufacturing Base and Competitors
Table 98. Celgene Corp Nuclear Receptor ROR Gamma Major Business
Table 99. Celgene Corp Nuclear Receptor ROR Gamma Total Revenue (USD Million) (2017-2018)
Table 100. Celgene Corp SWOT Analysis
Table 101. Celgene Corp Nuclear Receptor ROR Gamma Product and Services
Table 102. Celgene Corp Nuclear Receptor ROR Gamma Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Global Nuclear Receptor ROR Gamma Sales by Manufacturer (2018-2019) (K Pcs)
Table 104. Global Nuclear Receptor ROR Gamma Revenue by Manufacturer (2018-2019) (USD Million)
Table 105. Global Nuclear Receptor ROR Gamma Sales by Regions (2015-2020) (K Pcs)
Table 106. Global Nuclear Receptor ROR Gamma Sales Market Share by Regions (2015-2020)
Table 107. Global Nuclear Receptor ROR Gamma Revenue by Regions (2015-2020) (USD Million)
Table 108. North America Nuclear Receptor ROR Gamma Sales by Countries (2015-2020) (K Pcs)
Table 109. North America Nuclear Receptor ROR Gamma Sales Market Share by Countries (2015-2020)
Table 110. North America Nuclear Receptor ROR Gamma Revenue by Countries (2015-2020) (USD Million)
Table 111. North America Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2015-2020)
Table 112. Europe Nuclear Receptor ROR Gamma Sales by Countries (2015-2020) (K Pcs)
Table 113. Europe Nuclear Receptor ROR Gamma Sales Market Share by Countries (2015-2020)
Table 114. Europe Nuclear Receptor ROR Gamma Revenue by Countries (2015-2020) (USD Million)
Table 115. Asia-Pacific Nuclear Receptor ROR Gamma Sales by Regions (2015-2020) (K Pcs)
Table 116. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share by Regions (2015-2020)
Table 117. Asia-Pacific Nuclear Receptor ROR Gamma Revenue by Regions (2015-2020) (USD Million)
Table 118. South America Nuclear Receptor ROR Gamma Sales by Countries (2015-2020) (K Pcs)
Table 119. South America Nuclear Receptor ROR Gamma Sales Market Share by Countries (2015-2020)
Table 120. South America Nuclear Receptor ROR Gamma Revenue by Countries (2015-2020) (USD Million)
Table 121. South America Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2015-2020)
Table 122. Middle East & Africa Nuclear Receptor ROR Gamma Sales by Countries (2015-2020) (K Pcs)
Table 123. Middle East & Africa Nuclear Receptor ROR Gamma Sales Market Share by Countries (2015-2020)
Table 124. Middle East & Africa Nuclear Receptor ROR Gamma Revenue by Countries (2015-2020) (USD Million)
Table 125. Middle East & Africa Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2015-2020)
Table 126. Global Nuclear Receptor ROR Gamma Sales by Type (2015-2020) (K Pcs)
Table 127. Global Nuclear Receptor ROR Gamma Sales Share by Type (2015-2020)
Table 128. Global Nuclear Receptor ROR Gamma Revenue by Type (2015-2020) (USD Million)
Table 129. Global Nuclear Receptor ROR Gamma Revenue Share by Type (2015-2020)
Table 130. Global Nuclear Receptor ROR Gamma Sales by Application (2015-2020) (K Pcs)
Table 131. Global Nuclear Receptor ROR Gamma Sales Share by Application (2015-2020)
Table 132. Global Nuclear Receptor ROR Gamma Sales Forecast by Regions (2021-2025) (K Pcs)
Table 133. Global Nuclear Receptor ROR Gamma Market Share Forecast by Regions (2021-2025)
Table 134. Global Nuclear Receptor ROR Gamma Sales Forecast by Type (2021-2025) (K Pcs)
Table 135. Global Nuclear Receptor ROR Gamma Market Share Forecast by Type (2021-2025)
Table 136. Global Nuclear Receptor ROR Gamma Sales Forecast by Application (2021-2025)
Table 137. Global Nuclear Receptor ROR Gamma Market Share Forecast by Application (2021-2025)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nuclear Receptor ROR Gamma Picture
Figure 2. Global Sales Market Share of Nuclear Receptor ROR Gamma by Type in 2019
Figure 3. BBI-6000 Picture
Figure 4. GRC-39815Action Picture
Figure 5. R&D Progress Picture
Figure 6. GSK-2981278 Picture
Figure 7. IMU-366 Picture
Figure 8. INV-17 Picture
Figure 9. Others Picture
Figure 10. Nuclear Receptor ROR Gamma Sales Market Share by Application in 2018
Figure 11. Chronic Obstructive Pulmonary Disease Picture
Figure 12. Asthma Picture
Figure 13. Axial Spondyloarthritis Picture
Figure 14. Breast Cancer Picture
Figure 15. Others Picture
Figure 16. Global Nuclear Receptor ROR Gamma Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Nuclear Receptor ROR Gamma Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Nuclear Receptor ROR Gamma Sales Market Share by Manufacturer in 2019
Figure 37. Global Nuclear Receptor ROR Gamma Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Nuclear Receptor ROR Gamma Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Nuclear Receptor ROR Gamma Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 42. Global Nuclear Receptor ROR Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Nuclear Receptor ROR Gamma Revenue Market Share by Regions (2015-2020)
Figure 44. Global Nuclear Receptor ROR Gamma Revenue Market Share by Regions in 2018
Figure 45. North America Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
Figure 46. Europe Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
Figure 48. South America Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020)
Figure 50. North America Nuclear Receptor ROR Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Nuclear Receptor ROR Gamma Sales Market Share by Countries (2015-2020)
Figure 52. North America Nuclear Receptor ROR Gamma Sales Market Share by Countries in 2018
Figure 53. North America Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Nuclear Receptor ROR Gamma Revenue Market Share by Countries in 2018
Figure 55. United States Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Canada Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Mexico Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Europe Nuclear Receptor ROR Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Countries in 2019
Figure 61. Germany Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. UK Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. France Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Russia Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Italy Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Asia-Pacific Nuclear Receptor ROR Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Nuclear Receptor ROR Gamma Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Nuclear Receptor ROR Gamma Revenue Market Share by Regions 2019
Figure 69. China Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Korea Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. India Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Southeast Asia Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. South America Nuclear Receptor ROR Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Nuclear Receptor ROR Gamma Sales Market Share by Countries in 2019
Figure 76. South America Nuclear Receptor ROR Gamma Revenue Market Share by Countries in 2019
Figure 77. Brazil Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Argentina Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Middle East and Africa Nuclear Receptor ROR Gamma Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Nuclear Receptor ROR Gamma Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Nuclear Receptor ROR Gamma Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Nuclear Receptor ROR Gamma Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Egypt Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Turkey Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. South Africa Nuclear Receptor ROR Gamma Sales and Growth Rate (2015-2020) (K Pcs)
Figure 87. Global Nuclear Receptor ROR Gamma Sales and Growth Rate (2021-2025) (K Pcs)
Figure 88. Global Nuclear Receptor ROR Gamma Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Nuclear Receptor ROR Gamma Market Forecast (2021-2025) (K Pcs)
Figure 90. Europe Sales Nuclear Receptor ROR Gamma Market Forecast (2021-2025) (K Pcs)
Figure 91. Asia-Pacific Sales Nuclear Receptor ROR Gamma Market Forecast (2021-2025) (K Pcs)
Figure 92. South America Sales Nuclear Receptor ROR Gamma Market Forecast (2021-2025) (K Pcs)
Figure 93. Middle East & Africa Sales Nuclear Receptor ROR Gamma Market Forecast (2021-2025) (K Pcs)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
核内受容体RORガンマの世界市場（～2026年） Market Analysis and Insights: Global Nuclear Receptor ROR Gamma Market The global Nuclear Receptor ROR Gamma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Nuclear Receptor ROR Gamma Scope and Market Size Nuclear Rece…- 低親和性免疫グロブリンガンマFc領域受容体II-bの世界市場（～2026年） Market Analysis and Insights: Global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b Market The global Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global…
- ガンマアミノ酪酸受容体サブユニットガンマ2の世界市場（～2026年） Market Analysis and Insights: Global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 Market The global Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gamma-Aminobutyri…
- レチノイン酸受容体ガンマの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Retinoic Acid Receptor Gamma market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Retinoic Acid Re…
- レチノイン酸受容体ガンマの世界市場（～2026年） Market Analysis and Insights: Global Retinoic Acid Receptor Gamma Market The global Retinoic Acid Receptor Gamma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Retinoic Acid Receptor Gamma Scope and Market Size Retino…